New hope for failing fontan hearts: common drug gets specialized trial
NCT ID NCT06762964
Summary
This study is testing whether a medication called dapagliflozin, taken for six months, can help control heart pressures and improve symptoms in adults with a failing Fontan circulation—a complex heart condition they were born with. Researchers will measure changes in heart pressure during rest and light exercise using a specialized catheter. The goal is to see if this drug, already used for other heart conditions, can help manage this specific and challenging form of heart failure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SINGLE VENTRICLE HEART DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
Contact
Conditions
Explore the condition pages connected to this study.